# Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio

Page: https://stenobird.com/podcast/nucleate-podcast-6322042/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio
Text version: https://stenobird.com/podcast/nucleate-podcast-6322042/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio.md
Podcast: [Nucleate Podcast](https://stenobird.com/podcast/nucleate-podcast-6322042)
Published: 2026-06-04T04:00:00+00:00
Episode link: https://nucleate-signal.simplecast.com/episodes/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio-LPYba3d0
Audio file: https://cdn.simplecast.com/media/audio/transcoded/a2677e57-b5ce-490f-93be-59631c3a5218/6a0defb6-ad56-4c08-b015-fea36f1c159f/episodes/audio/group/14d04bef-f536-4cf6-9390-3aad01fbd022/group-item/e0eb927a-fdf1-46dd-8ad2-b25695c222b5/128_default_tc.mp3?aid=rss_feed&feed=OdcQl6Pu
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio
Duration seconds: 3975

## Resource

In this episode of the Nucleate podcast, Jodie Morrison, CEO of Q32 Bio, discusses her extensive career path from clinical research to executive leadership. She explains her strategic approach to leading companies, particularly in challenging "fixer-upper" scenarios where she prioritizes finding assets with "good bones" and building high-performing, mission-driven teams. She also details Q32 Bio's current focus on autoimmune disorders like alopecia areata, emphasizing the pursuit of safer biologic treatments for patients who currently face significant unmet needs. Beyond her corporate role, Morrison highlights her efforts to foster community among biotech leaders through the founding of the CEO Forum during the COVID-19 pandemic. She advocates for transparency and mentorship, particularly for women in the industry, encouraging them to "lift while they climb". Looking ahead, she expresses cautious optimism for the biotech sector, noting that while capital markets and public sentiment present hurdles, the persistent reality of human disease ensures a continuous need for scientific advancement and new therapies.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/nucleate-podcast-6322042/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.